Nucs AI Products

Discover our advanced AI solutions for personalized and precise clinical prostate cancer management.

Radiologist reviewing a PSMA-PET/CT scan on a computer screen with a patient, showcasing advanced AI analysis for prostate cancer treatment.
Comprehensive Tumor Analysis

Fast and reproducible whole-body tumor burden quantification in PSMA-PET/CT imaging, delivering critical insights on tumor characteristics.

Accurate Detection

Automatic identification of tumor lesions.

Cancer Staging

Automatic localization of lesions by  TNM classification.

Tumor Quantification

Precise calculation of whole-body tumor burden metrics.
Two healthcare professionals discussing patient outcomes on a tablet, utilizing Nucs AI’s SelectPSMA for advanced prostate cancer treatment.
Personalized Treatment Predictions

AI-powered predictions of patient outcomes following treatment with PSMA-targeted radiopharmaceuticals, helping to avoid ineffective treatments and side effects.

Patient Selection

Identifies patients unlikely to benefit from treatment with 177Lu-PSMA-617.

Precision Medicine

Improves patient outcome while minimizing treatment-related side effects.

Evidence-Based Decisions

Assists phyisicians in clinical decision-making process with robust data.

Contact us today

Take the next step to discover how Nucs AI can transform your clinical management of prostate cancer care.